Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy | Zendy

Michael H. Davidson | Zendy; Robert S. Rosenson | Zendy; Kevin C. Maki | Zendy; Stephen J. Nicholls | Zendy; Christie M. Ballantyne | Zendy; Theodore Mazzone | Zendy; Dawn M. Carlson | Zendy; Laura A. Williams | Zendy; Maureen T. Kelly | Zendy; Heidi S. Camp | Zendy; Aditya Lele | Zendy; James C. Stolzenbach | Zendy

Open Access

Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy

Author(s) -

Michael H. Davidson,

Robert S. Rosenson,

Kevin C. Maki,

Stephen J. Nicholls,

Christie M. Ballantyne,

Theodore Mazzone,

Dawn M. Carlson,

Laura A. Williams,

Maureen T. Kelly,

Heidi S. Camp,

Aditya Lele,

James C. Stolzenbach

Publication year - 2014

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.113.302926

Subject(s) - atorvastatin , dyslipidemia , medicine , fenofibrate , statin , intima media thickness , coronary artery disease , fibrate , placebo , rosuvastatin , cardiology , gastroenterology , endocrinology , urology , carotid arteries , disease , pathology , alternative medicine

To assess whether adding a fibrate to statin therapy reduces residual cardiovascular risk associated with elevated triglycerides and low high-density lipoprotein cholesterol, The Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) trial evaluated the effects of fenofibric acid (FA) treatment on cIMT in patients with mixed dyslipidemia on atorvastatin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research